$OMEX
ODYSSEY MARINE EXPLORATION INC Stock $omex

$omex Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000119312514406075 Filed on November 10, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q3
Revenue	$288.5K	$120.0K	$5.554M
YoY Change	-98.33%	-97.84%	487.09%
Cost Of Revenue	$40.00K	$27.03K	$169.6K
YoY Change	-85.71%	-84.06%	212.65%
Gross Profit	$245.9K	$93.02K	$5.385M
YoY Change	-98.55%	-98.27%	503.78%
Gross Profit Margin	85.24%	77.49%	96.95%
Selling, General & Admin	$6.120M	$2.782M	$4.670M
YoY Change	-41.1%	-40.42%	56.42%
% of Gross Profit	2488.66%	2991.14%	86.73%
Research & Development			$9.200M
YoY Change
% of Gross Profit			170.84%
Depreciation & Amortization	$1.710M	$2.470M	$500.0K
YoY Change	216.67%	394.0%	28.21%
% of Gross Profit	695.36%	2655.34%	9.29%
Operating Expenses	$6.120M	$7.924M	$8.999M
YoY Change	-41.15%	-11.95%	39634.99%
Operating Profit	-$5.874M	-$7.804M	-$3.445M
YoY Change	-189.57%	126.54%	-473.03%
Interest Expense	-$300.0K	$268.9K	$894.1K
YoY Change	-111.15%	-69.93%	-53.69%
% of Operating Profit
Other Income/Expense, Net	-$10.00K	$130.0K	$95.43K
YoY Change	-102.27%	36.23%	-96.69%
Pretax Income	-$6.190M	-$7.674M	-$3.349M
YoY Change	-163.81%	129.12%	-188.07%
Income Tax	$0.00	$0.00	$235.2K
% Of Pretax Income
Net Earnings	-$5.243M	-$7.415M	-$3.585M
YoY Change	-148.77%	106.86%	-194.26%
Net Earnings / Revenue	-1817.54%	-6176.9%	-64.53%
Basic Earnings Per Share		-$0.09	-$0.01
Diluted Earnings Per Share	-$737.0K	-$0.09	-$0.01
COMMON SHARES
Basic Shares Outstanding	85.32M shares	85.27M shares	80.25M shares
Diluted Shares Outstanding		85.27M shares	80.25M shares

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.140M	$3.710M	$11.17M
YoY Change	-85.27%	-66.79%	419.53%
Cash & Equivalents	$3.144M	$3.712M	$11.17M
Short-Term Investments
Other Short-Term Assets	$655.7K	$598.3K	$1.167M
YoY Change	-39.31%	-48.72%	-36.92%
Inventory	$675.0K	$676.4K	$342.7K
Prepaid Expenses	$650.2K
Receivables	$6.476M	$6.420M	$6.682M
Other Receivables	$60.00K	$50.00K
Total Short-Term Assets	$11.47M	$12.07M	$19.93M
YoY Change	-65.87%	-39.42%	-1.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.236M	$8.806M	$9.098M
YoY Change	-26.0%	-3.21%	34.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.272M	$1.290M	$1.269M
YoY Change	-55.61%	1.68%	-80.48%
Total Long-Term Assets	$13.62M	$15.23M	$15.58M
YoY Change	-23.71%	-2.29%	17.52%
TOTAL ASSETS
Total Short-Term Assets	$11.47M	$12.07M	$19.93M
Total Long-Term Assets	$13.62M	$15.23M	$15.58M
Total Assets	$25.09M	$27.30M	$35.51M
YoY Change	-51.25%	-23.12%	5.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.071M	$3.832M	$2.411M
YoY Change	46.03%	58.96%	-2.4%
Accrued Expenses	$2.388M	$3.213M	$4.407M
YoY Change	-54.9%	-27.09%	-16.54%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.360M	$9.360M	$20.83M
YoY Change	-42.82%	-55.06%	-13.24%
Total Short-Term Liabilities	$19.04M	$19.37M	$33.63M
YoY Change	-31.87%	-42.4%	-26.42%
LONG-TERM LIABILITIES
Long-Term Debt	$11.81M	$7.980M	$1.700M
YoY Change	108.66%	369.41%	-68.34%
Other Long-Term Liabilities	$4.640M	$4.640M	$4.640M
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Liabilities	$16.45M	$12.62M	$6.345M
YoY Change	59.63%	98.98%	-36.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.04M	$19.37M	$33.63M
Total Long-Term Liabilities	$16.45M	$12.62M	$6.345M
Total Liabilities	$35.49M	$32.00M	$39.98M
YoY Change	-7.21%	-19.96%	-28.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$202.4M	-$197.2M	-$186.7M
YoY Change	15.05%	5.61%
Common Stock	$198.3M	$8.532K	$8.148K
YoY Change	2.61%	4.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.40M	-$4.701M	-$1.563M
YoY Change
Total Liabilities & Shareholders Equity	$25.09M	$27.30M	$35.51M
YoY Change	-51.25%	-23.12%	5.81%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q3
OPERATING ACTIVITIES
Net Income	-$5.243M	-$7.415M	-$3.585M
YoY Change	-148.77%	106.86%	-194.26%
Depreciation, Depletion And Amortization	$1.710M	$2.470M	$500.0K
YoY Change	216.67%	394.0%	28.21%
Cash From Operating Activities	-$5.530M	-$6.560M	-$8.260M
YoY Change	-136.6%	-20.58%	-29.1%
INVESTING ACTIVITIES
Capital Expenditures	-$140.0K	-$180.0K	-$660.0K
YoY Change	-88.43%	-72.73%	164.0%
Acquisitions
YoY Change
Other Investing Activities		$0.00	-$1.250M
YoY Change		-100.0%
Cash From Investing Activities	-$140.0K	-$180.0K	-$1.910M
YoY Change	-450.0%	-90.58%	664.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.100M	4.730M	11.01M
YoY Change	-202.0%	-57.04%	4.66%
NET CHANGE
Cash From Operating Activities	-5.530M	-6.560M	-8.260M
Cash From Investing Activities	-140.0K	-180.0K	-1.910M
Cash From Financing Activities	5.100M	4.730M	11.01M
Net Change In Cash	-570.0K	-2.010M	840.0K
YoY Change	-105.62%	-339.29%	-160.87%
FREE CASH FLOW
Cash From Operating Activities	-$5.530M	-$6.560M	-$8.260M
Capital Expenditures	-$140.0K	-$180.0K	-$660.0K
Free Cash Flow	-$5.390M	-$6.380M	-$7.600M
YoY Change	-133.03%	-16.05%	-33.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q4	omex	Number Of Securities Called By Warrants Or Rights Upon Additional Financing NumberOfSecuritiesCalledByWarrantsOrRightsUponAdditionalFinancing	434027	shares
CY2012Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.60
CY2012Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	8000000
CY2012Q2	omex	Number Of Securities Called By Warrants Or Rights Upon Additional Financing NumberOfSecuritiesCalledByWarrantsOrRightsUponAdditionalFinancing	434027	shares
CY2012Q2	omex	Issued Warrants To Acquire Common Shares IssuedWarrantsToAcquireCommonShares	260417	shares
CY2013Q3	omex	Debt Instrument Basis Spread On Variable Rate Points DebtInstrumentBasisSpreadOnVariableRatePoints	0.0075	pure
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	85321008	shares
CY2014Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	522500	shares
CY2010Q4	omex	Class Of Warrant Or Right Warrants Issued ClassOfWarrantOrRightWarrantsIssued	1800000	shares
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11173036
CY2013Q3	omex	Derivative Financial Instruments Fair Value Assumptions Linked Common Shares DerivativeFinancialInstrumentsFairValueAssumptionsLinkedCommonShares	1562500	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85321008	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	85321008	shares
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2014Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.32
CY2014Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	9675200	shares
CY2014Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2014Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	666361
CY2014Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	371332
CY2014Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	58569472
CY2014Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	4643750
CY2014Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20735130
CY2014Q3	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	19374334
CY2014Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12624508
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	8532
CY2014Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3832010
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-197183901
CY2014Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	9955000
CY2014Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3212858
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8805901
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	-4700842
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27298000
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197841727
CY2014Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1125749
CY2014Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1840404
CY2014Q3	us-gaap	Minority Interest MinorityInterest	-5367203
CY2014Q3	us-gaap	Liabilities Liabilities	31998842
CY2014Q3	us-gaap	Deferred Revenue DeferredRevenue	6484154
CY2014Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4631593
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3711573
CY2014Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	664348
CY2014Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	400000
CY2014Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	4200000
CY2014Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	2700000
CY2014Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	18800000
CY2014Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	127400000
CY2014Q3	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	24757344
CY2014Q3	us-gaap	Assets Assets	27298000
CY2014Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2014Q3	us-gaap	Inventory Net InventoryNet	676367
CY2014Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	11900000
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6420437
CY2014Q3	us-gaap	Other Assets Current OtherAssetsCurrent	598349
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1289802
CY2014Q3	us-gaap	Retail Related Inventory Merchandise RetailRelatedInventoryMerchandise	759797
CY2014Q3	us-gaap	Assets Current AssetsCurrent	12071074
CY2014Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	5131223
CY2014Q3	us-gaap	Retail Related Inventory Packaging And Other Supplies RetailRelatedInventoryPackagingAndOtherSupplies	73492
CY2014Q3	omex	Inventory Current And Non Current Net InventoryCurrentAndNonCurrentNet	5807590
CY2014Q3	omex	Building And Land BuildingAndLand	4783687
CY2014Q3	omex	Revenue Participation Agreement Value RevenueParticipationAgreementValue	15000000
CY2014Q3	omex	Mortgage And Loans Payable Current And Non Current MortgageAndLoansPayableCurrentAndNonCurrent	17344071
CY2014Q3	omex	Mortgage And Loans Payable Current MortgageAndLoansPayableCurrent	9363313
CY2014Q3	omex	Mortgage And Loans Payable Non Current MortgageAndLoansPayableNonCurrent	7980758
CY2014Q3	omex	Noncurrent Assets Excluding Property Plant And Equipment NoncurrentAssetsExcludingPropertyPlantAndEquipment	6421025
CY2014Q3	omex	Derivative Financial Instruments Fair Value Assumptions Quoted Market Price DerivativeFinancialInstrumentsFairValueAssumptionsQuotedMarketPrice	2.50
CY2014Q3	omex	Maximum Issue Of Warrants To Purchase Common Stock MaximumIssueOfWarrantsToPurchaseCommonStock	1302083	shares
CY2014Q3	omex	Artifacts Artifacts	5345633
CY2014Q3	omex	Class Of Warrant Or Right Adjusted Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights	3.60
CY2014Q3	omex	Derivative Financial Instruments Fair Value Assumptions Linked Common Shares DerivativeFinancialInstrumentsFairValueAssumptionsLinkedCommonShares	1562500	shares
CY2011Q4	omex	Accounts Receivables Transferred Between Related Parties AccountsReceivablesTransferredBetweenRelatedParties	8227675
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10096414
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27947841
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16973085
CY2013Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	3817147	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	83882577	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	83882577	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	9675200	shares
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17326829
CY2013Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	371332
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	51625159
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	4643750
CY2013Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10305976
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	8388
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3472612
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-175954138
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5294420
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	13206790
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51460607
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	193272576
CY2013Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	970823
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1840404
CY2013Q4	us-gaap	Minority Interest MinorityInterest	-4120039
CY2013Q4	us-gaap	Liabilities Liabilities	38253817
CY2013Q4	us-gaap	Deferred Revenue DeferredRevenue	6484154
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5131593
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21322257
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9778252
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10685732
CY2013Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	21995031
CY2013Q4	us-gaap	Assets Assets	51460607
CY2013Q4	us-gaap	Inventory Net InventoryNet	314738
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	207005
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1080364
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2865941
CY2013Q4	us-gaap	Retail Related Inventory Merchandise RetailRelatedInventoryMerchandise	401072
CY2013Q4	us-gaap	Assets Current AssetsCurrent	33610096
CY2013Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	5206318
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10390087
CY2013Q4	us-gaap	Retail Related Inventory Packaging And Other Supplies RetailRelatedInventoryPackagingAndOtherSupplies	85133
CY2013Q4	omex	Inventory Current And Non Current Net InventoryCurrentAndNonCurrentNet	5521056
CY2013Q4	omex	Building And Land BuildingAndLand	4756306
CY2013Q4	omex	Mortgage And Loans Payable Current And Non Current MortgageAndLoansPayableCurrentAndNonCurrent	22031808
CY2013Q4	omex	Mortgage And Loans Payable Current MortgageAndLoansPayableCurrent	16369582
CY2013Q4	omex	Mortgage And Loans Payable Non Current MortgageAndLoansPayableNonCurrent	5662226
CY2013Q4	omex	Noncurrent Assets Excluding Property Plant And Equipment NoncurrentAssetsExcludingPropertyPlantAndEquipment	8072259
CY2013Q4	omex	Artifacts Artifacts	5406183
CY2013Q4	omex	Derivative Financial Instruments Fair Value Assumptions Linked Common Shares DerivativeFinancialInstrumentsFairValueAssumptionsLinkedCommonShares	1562500	shares
CY2010Q2	omex	Marine Service Account Receivables MarineServiceAccountReceivables	2000000
	us-gaap	Interest Expense Debt InterestExpenseDebt	1295833
	us-gaap	Interest Expense Debt InterestExpenseDebt	279070
CY2014Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	5225	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-34772729
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78991192	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	3.18
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78991192	shares
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	284339
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6565579
	us-gaap	Profit Loss ProfitLoss	-21492748
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	506055
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-434116
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	7826086
	us-gaap	Operating Income Loss OperatingIncomeLoss	-23532924
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1342991
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	6829
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-24063403
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-530479
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	2206642
	us-gaap	Revenues Revenues	6671277
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1250000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3286521
	us-gaap	Net Income Loss NetIncomeLoss	-24399394
	us-gaap	Interest Paid InterestPaid	392719
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4682426
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	139667
	us-gaap	Gain On Derivative Instruments Pretax GainOnDerivativeInstrumentsPretax	2206642
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	756795
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2123706
	us-gaap	Interest Expense InterestExpense	2883617
	us-gaap	Operating Expenses OperatingExpenses	30204201
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	160154
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1076622
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	335991
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	410357
	us-gaap	Depreciation Depreciation	1398541
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1641325
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	40385872
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6039905
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-9719353
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4536521
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	453770
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2906646
	us-gaap	Share Based Compensation ShareBasedCompensation	2123706
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	10000000
	omex	Expedition Charter Revenue ExpeditionCharterRevenue	5480
	omex	Shares Used In Computation For Earning Per Share Basic SharesUsedInComputationForEarningPerShareBasic	78991192	shares
	omex	Redemptions Of Senior Convertible Notes RedemptionsOfSeniorConvertibleNotes	863651
	omex	Operations And Research OperationsAndResearch	19403757
	omex	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-21492748
	omex	Exhibit Revenue ExhibitRevenue	100218
	omex	Proceeds From Sale Of Subsidiary Stock ProceedsFromSaleOfSubsidiaryStock	25000000
	omex	Investment In Consolidated Entity InvestmentInConsolidatedEntity	-301093
	omex	Senior Convertible Debit Interest Settled With Common Stock Issuance SeniorConvertibleDebitInterestSettledWithCommonStockIssuance	489961
	omex	Settlement Of Vendor Payable With Subsidiary Stock SettlementOfVendorPayableWithSubsidiaryStock	625000
	omex	Repayment Of Mortgage And Loans Payable RepaymentOfMortgageAndLoansPayable	654033
	omex	Prior Period Accrued Compensation Paid By Equity Instruments PriorPeriodAccruedCompensationPaidByEquityInstruments	165748
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
	dei	Document Type DocumentType	10-Q
	dei	Entity Registrant Name EntityRegistrantName	ODYSSEY MARINE EXPLORATION INC
	dei	Trading Symbol TradingSymbol	OMEX
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-23001668
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2007-08-17
	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	4.32
	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> Management used estimates and assumptions in preparing these financial statements in accordance with generally accepted accounting principles. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were used.</p> </div>
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84707367	shares
	us-gaap	Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable	2014-04-13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	dei	Entity Central Index Key EntityCentralIndexKey	0000798528
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
	us-gaap	Line Of Credit Facility Interest Rate Description LineOfCreditFacilityInterestRateDescription	Prime rate plus three-fourths of one percent (0.75%)
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	1.69
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84707367	shares
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-21384
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6944313
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	982912
	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	253347
	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	45000
	us-gaap	Profit Loss ProfitLoss	-21229763
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2043110
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	286534
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2347826
	us-gaap	Operating Income Loss OperatingIncomeLoss	-22319219
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	676820
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	25194
	us-gaap	Income Taxes Paid IncomeTaxesPaid	15000
	us-gaap	Recovery Of Direct Costs RecoveryOfDirectCosts	6290465
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-22957984
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	246653
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-638765
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	676820
	us-gaap	Revenues Revenues	1034396
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	500000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2830198
	us-gaap	Net Income Loss NetIncomeLoss	-22476929
	us-gaap	Interest Paid InterestPaid	648547
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6213432
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	113540
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-522500
	us-gaap	Gain On Derivative Instruments Pretax GainOnDerivativeInstrumentsPretax	676820
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1827767
	us-gaap	Interest Expense InterestExpense	931819
	us-gaap	Operating Expenses OperatingExpenses	23353615
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	10000000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8191210
	us-gaap	Transfer To Investments TransferToInvestments	522500
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	15046
	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	10750
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-17610684
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-481055
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	204516
	us-gaap	Depreciation Depreciation	3802547
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	302744
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	8221182
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1750527
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2830198
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	359400
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1247166
	us-gaap	Share Based Compensation ShareBasedCompensation	1785306
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	12684514
	omex	Short Term Investments Maturity Period ShortTermInvestmentsMaturityPeriod	Three months or less
	omex	Net Operating Loss Carry Back Period Original NetOperatingLossCarryBackPeriodOriginal	P2Y
	omex	Borrowing Base Value Of Secured Collateral Percentage BorrowingBaseValueOfSecuredCollateralPercentage	0.40	pure
	omex	Shares Used In Computation For Earning Per Share Basic SharesUsedInComputationForEarningPerShareBasic	84707367	shares
	omex	Operations And Research OperationsAndResearch	14957889
	omex	Period For Registration Statement Subject To Review PeriodForRegistrationStatementSubjectToReview	120 days thereafter
	omex	Investment Repayment Period InvestmentRepaymentPeriod	P3Y
	omex	Estimated Annual Effective Tax Rate EstimatedAnnualEffectiveTaxRate	0.3237	pure
	omex	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-21229763
	omex	Number Of Stock Incentive Plans NumberOfStockIncentivePlans	1	Incentive_Plan
	omex	Percentage Of Debt Instrument Conversion Price On Market Price Of Common Stock PercentageOfDebtInstrumentConversionPriceOnMarketPriceOfCommonStock	1.250	pure
	omex	Period For Warrant Term PeriodForWarrantTerm	P5Y6M
	omex	Net Operating Loss Carry Back Period One NetOperatingLossCarryBackPeriodOne	P5Y
	omex	Net Operating Loss Carried Forward Available For Offsetting Against Future Taxable Income Percentage NetOperatingLossCarriedForwardAvailableForOffsettingAgainstFutureTaxableIncomePercentage	1.00	pure
	omex	Dividends Received From Subsidiary DividendsReceivedFromSubsidiary	21500000
	omex	Secured Collateral SecuredCollateral	24700	Coins
	omex	Percentage Of Acceleration Payment Of Remaining Face Value PercentageOfAccelerationPaymentOfRemainingFaceValue	1.25	pure
	omex	Period For Registration Statement To Be Declared Effective PeriodForRegistrationStatementToBeDeclaredEffective	90 days thereafter
	omex	Exhibit Revenue ExhibitRevenue	51484
	omex	Payment Restricted Cash Held As Collateral On Loan Payable PaymentRestrictedCashHeldAsCollateralOnLoanPayable	-10000000
	omex	Period For Anniversary Of Initial Closing Date PeriodForAnniversaryOfInitialClosingDate	Five-year period beginning on the six-month
	omex	Distribution Ratio Of Remaining Net Proceed DistributionRatioOfRemainingNetProceed	0.25	pure
	omex	Federal Tax Benefit Related To Operating Loss Carryforwards FederalTaxBenefitRelatedToOperatingLossCarryforwards	0
	omex	Senior Convertible Debit Interest Settled With Common Stock Issuance SeniorConvertibleDebitInterestSettledWithCommonStockIssuance	73037
	omex	Shares Of Common Stock Issuable Upon Exercise Of Warrant SharesOfCommonStockIssuableUponExerciseOfWarrant	434027	shares
	omex	Period For Registration Statement Of Initial Closing Date PeriodForRegistrationStatementOfInitialClosingDate	P6M
	omex	Prior Period Accrued Compensation Paid By Equity Instruments PriorPeriodAccruedCompensationPaidByEquityInstruments	113126
	omex	Number Of Financial Institutions In Which Cash Deposited NumberOfFinancialInstitutionsInWhichCashDeposited	1	Institution
	omex	Repayment Of Mortgage And Loans Payable RepaymentOfMortgageAndLoansPayable	14463332
	omex	Net Operating Loss Carried Forward Available For Offsetting Against Future Taxable Income Percentage As Original NetOperatingLossCarriedForwardAvailableForOffsettingAgainstFutureTaxableIncomePercentageAsOriginal	0.90	pure
	omex	Reversal Of Bad Debt Provision ReversalOfBadDebtProvision	522500
	omex	Percentage Of Cash Proceeds From Monetization Of Recovered Cargo PercentageOfCashProceedsFromMonetizationOfRecoveredCargo	0.80	pure
	omex	Percentage Of Subsequent Cash Proceeds After Reimbursement PercentageOfSubsequentCashProceedsAfterReimbursement	0.45	pure
CY2013	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	24000000	shares
	omex	Percentage Of Adjusted Conversion Price Of Quoted Market Prices PercentageOfAdjustedConversionPriceOfQuotedMarketPrices	0.75	pure
CY2013	omex	Proceeds From Sale Of Subsidiary Stock ProceedsFromSaleOfSubsidiaryStock	27500000
CY2011	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	2500000	shares
CY2011	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2500000
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80252203	shares
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2013Q3	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	3.28
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80252203	shares
CY2013Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5534933
CY2013Q3	us-gaap	Profit Loss ProfitLoss	-931393
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3444721
CY2013Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	640153
CY2013Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	4074
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3349290
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	95431
CY2013Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	870453
CY2013Q3	us-gaap	Revenues Revenues	5554460
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-3584539
CY2013Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	114980
CY2013Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	882933
CY2013Q3	us-gaap	Interest Expense InterestExpense	894076
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	8999181
CY2013Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4670196
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	235249
CY2013Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	169573
CY2013Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2653146
CY2013Q3	omex	Shares Used In Computation For Earning Per Share Basic SharesUsedInComputationForEarningPerShareBasic	80252203	shares
CY2013Q3	omex	Redemptions Of Senior Convertible Notes RedemptionsOfSeniorConvertibleNotes	230300
CY2013Q3	omex	Operations And Research OperationsAndResearch	4159412
CY2013Q3	omex	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-931393
CY2013Q3	omex	Share Based Compensation Arrangement By Share Based Payment Award Options Issued ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssued	0	shares
CY2013Q3	omex	Exhibit Revenue ExhibitRevenue	19527
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85271429	shares
CY2014Q3	us-gaap	Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable	2013-10-11
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2014Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.000	pure
CY2014Q3	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	1.22
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85271429	shares
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	95046
CY2014Q3	us-gaap	Profit Loss ProfitLoss	-7415124
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7803841
CY2014Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	305841
CY2014Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	557
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7673838
CY2014Q3	us-gaap	Recovery Of Direct Costs RecoveryOfDirectCosts	2783505
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	130003
CY2014Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	305841
CY2014Q3	us-gaap	Revenues Revenues	120046
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-7673838
CY2014Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	92497
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	607106
CY2014Q3	us-gaap	Interest Expense InterestExpense	268892
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	7923887
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2782362
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	27026
CY2014Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-258714
CY2014Q3	omex	Shares Used In Computation For Earning Per Share Basic SharesUsedInComputationForEarningPerShareBasic	85271429	shares
CY2014Q3	omex	Operations And Research OperationsAndResearch	5114499
CY2014Q3	omex	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-7415124
CY2014Q3	omex	Share Based Compensation Arrangement By Share Based Payment Award Options Issued ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssued	0	shares
CY2014Q3	omex	Exhibit Revenue ExhibitRevenue	25000

Files In Submission

Name	View Source	Status
0001193125-14-406075-index-headers.html	Edgar Link	pending
0001193125-14-406075-index.html	Edgar Link	pending
0001193125-14-406075.txt	Edgar Link	pending
0001193125-14-406075-xbrl.zip	Edgar Link	pending
d776853d10q.htm	Edgar Link	pending
d776853dex101.htm	Edgar Link	pending
d776853dex102.htm	Edgar Link	pending
d776853dex311.htm	Edgar Link	pending
d776853dex312.htm	Edgar Link	pending
d776853dex321.htm	Edgar Link	pending
d776853dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g776853g03l19.jpg	Edgar Link	pending
omex-20140930.xml	Edgar Link	completed
omex-20140930.xsd	Edgar Link	pending
omex-20140930_cal.xml	Edgar Link	unprocessable
omex-20140930_def.xml	Edgar Link	unprocessable
omex-20140930_lab.xml	Edgar Link	unprocessable
omex-20140930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OMEX
ODYSSEY MARINE EXPLORATION INC Stock $omex

2014 Q4 Form 10-Q Financial Statement

#000119312514406075 Filed on November 10, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMEX ODYSSEY MARINE EXPLORATION INC Stock $omex

2014 Q4 Form 10-Q Financial Statement

#000119312514406075 Filed on November 10, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMEX
ODYSSEY MARINE EXPLORATION INC Stock $omex